<?xml version="1.0" encoding="UTF-8"?>
<p>Dengue virus (DENV, genus 
 <italic>Flavivirus</italic>, family 
 <italic>Flaviviridae</italic>) is an arbovirus with at least four distinct serotypes (DENV1, DENV2, DENV3, and DENV4) that confer homologous immunity [
 <xref rid="pntd.0006990.ref001" ref-type="bibr">1</xref>]. Manifestations of DENV infection range from completely asymptomatic in as many as three quarters of cases, to dengue hemorrhagic fever (DHF) and dengue shock-syndrome (DSS), with an intervening continuum of febrile symptoms and nonspecific signs of infection such as headache and rash [
 <xref rid="pntd.0006990.ref002" ref-type="bibr">2</xref>]. Dengue occurs primarily in tropical and sub-tropical latitudes with an estimated burden of 390 million cases annually, of which 96 million cases manifest symptomatically [
 <xref rid="pntd.0006990.ref003" ref-type="bibr">3</xref>]. These figures represent a thirty-fold increase in disease globally over the last fifty years that exposes nearly three billion people to the risk of infection [
 <xref rid="pntd.0006990.ref004" ref-type="bibr">4</xref>]. The heaviest burden is in Asia, with an estimated 67 million symptomatic cases annually, followed by the Americas, with 13 million, of which more than half occur in Brazil and Mexico [
 <xref rid="pntd.0006990.ref003" ref-type="bibr">3</xref>].
</p>
